$ Value
$165K
Shares
15,000
Price
$11
Filed
Nov 21
Insider
Name
Gould Robert J
Title
—
CIK
0001577034
Roles
Transaction Details
Transaction Date
2025-11-19
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
484,864
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2025. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.50 to $11.18, inclusive. The reporting person undertakes to provide to Fulcrum Therapeutics, Inc., any security holder of Fulcrum Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.